About the Kwok-Kin Wong, MD PhD Laboratory:

The Wong laboratory is a translational oncology laboratory at the Perlmutter Cancer Center, whose goal is to improve the outcomes of lung cancer patients. The lab focuses on advancing the understanding of genetic and tumor immune alterations involved in lung tumorigenesis, pathogenesis, therapeutic target and drug resistance mechanism. The Wong laboratory has been an instrumental evolving lung cancer into a genetically stratified disease and changing how lung cancer patients are treated. The laboratory has pioneered generating and utilizing genetically engineered mouse lung cancer models to validate oncogenic drivers and test novel therapeutics against specific genetic oncogenic drivers. These preclinical models are now being used to lead the next revolution in lung cancer treatment through the combined assessment of genetics and tumor immunology. The Wong laboratory is highly collaborative and works with numerous premier academic investigators and pharmaceutical companies to discovery and delineate the clinical path for novel therapeutic agents. The laboratory publishes in high- impact journals such as Nature , Nature Medicine and Cancer Cell . Recent postdoctoral fellows trained in the Wong laboratory are now investigators at numerous biotech and pharmaceutical companies.

Dr. Wong is an internationally renowned physician-scientist, New York University School of Medicine’s Anne Murnick Cogan and David H. Cogan Professor in Oncology and chief of hematology and medical oncology. He is also a member of the American Society of Clinical Investigation, the nation’s oldest honor society for physician-scientists.

In addition to world-class research facilities, NYULH also has a robust career development program led by our Office of Postdoctoral Affairs. One of only 17 schools to receive an NIH BEST (Broadening Experiences in Scientific Training), the Office of Postdoctoral Affairs offers over 30 courses and workshops on career planning, communication skills, negotiating, and conflict management, as well as career-specific training for careers in academia, pharma/biotech, science policy, medical communications, and many more. More information is available

at www.med.nyu.edu/postdoc, or you can email questions to postdoc-info@nyumc.org

The lab currently has several positions open. Job scope includes working with basic scientists leading and academic clinicians, the successful candidate will do ground breaking work to elucidate fundamental understanding of the molecular underpinnings of lung cancer. The successful candidate will do pioneering work on the interplay of genetics, tumor immune infiltrate and therapeutics in preclinical lung cancer models, with the ultimate goal of developing rational treatment hypotheses to be tested in the clinic.

This work will generate understanding of drug mechanism of actions and development of novel treatments / combinations, novel biomarkers and identify new targets for novel therapeutics. The successful candidate will also effectively communicate their work by writing manuscripts and successfully publishing their results in premier journals.